These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20429423)

  • 1. FOXP3+ regulatory T-cells in chronic kidney disease: molecular pathways and clinical implications.
    Meier P
    Adv Exp Med Biol; 2009; 665():163-70. PubMed ID: 20429423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD.
    Meier P; Golshayan D; Blanc E; Pascual M; Burnier M
    J Am Soc Nephrol; 2009 Jun; 20(6):1368-84. PubMed ID: 19406979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose IL-2 expands CD4
    Li Y; Liu X; Wang W; Wang S; Zhang J; Jiang S; Wang Y; Li L; Li J; Zhang Y; Huang H
    Ren Fail; 2018 Nov; 40(1):280-288. PubMed ID: 29619880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and function of Foxp3(+) regulatory T cells.
    Wang YM; Ghali J; Zhang GY; Hu M; Wang Y; Sawyer A; Zhou JJ; Hapudeniya DA; Wang Y; Cao Q; Zheng G; Harris DC; Alexander SI
    Nephrology (Carlton); 2016 Feb; 21(2):81-5. PubMed ID: 26461175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance.
    Alessandrini A; Turka LA
    Am J Kidney Dis; 2017 May; 69(5):667-674. PubMed ID: 28049555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.
    Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; van Dam T; Ijzermans JN; Weimar W; Baan CC
    Transplantation; 2010 Mar; 89(6):655-66. PubMed ID: 20164820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells in acute and chronic kidney diseases.
    Sharma R; Kinsey GR
    Am J Physiol Renal Physiol; 2018 May; 314(5):F679-F698. PubMed ID: 28877881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death.
    Reardon C; Wang A; McKay DM
    J Immunol; 2008 Jun; 180(12):8316-26. PubMed ID: 18523298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity and Stability in Foxp3+ Regulatory T Cells.
    Min B
    J Interferon Cytokine Res; 2017 Sep; 37(9):386-397. PubMed ID: 28696819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
    Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
    Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
    Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
    J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells in kidney disease and transplantation.
    Hu M; Wang YM; Wang Y; Zhang GY; Zheng G; Yi S; O'Connell PJ; Harris DC; Alexander SI
    Kidney Int; 2016 Sep; 90(3):502-14. PubMed ID: 27263492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
    Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
    Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro.
    Frassanito MA; Ruggieri S; Desantis V; Di Marzo L; Leone P; Racanelli V; Fumarulo R; Dammacco F; Vacca A
    Eur J Haematol; 2015 Jul; 95(1):65-74. PubMed ID: 25409753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.
    Arandi N; Mirshafiey A; Abolhassani H; Jeddi-Tehrani M; Edalat R; Sadeghi B; Shaghaghi M; Aghamohammadi A
    Scand J Immunol; 2013 May; 77(5):405-12. PubMed ID: 23432692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.